First Metformin Gum Patent
15th Nov 2006, 02:57 GMT
Filed under: Type 2, Adult Onset, Drugs, Products Sink your teeth into this one. Generex, the company that is quickly making a name for itself as the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced that it has been granted the first patent for its medicinal gum platform. The patent is titled Compositions for Oral Transmucosal Delivery of Metformin. It covers claims to the composition, processes, and methodologies for the delivery of an oral transmucosal metformin composition via the oral mucosal membrane for absorption. Long story short: you chew it. Metformin is a generic drug used to regulate blood sugar levels by reducing the amount of glucose produced by the liver. The popular brand names of Metformin include: Glucophage, Diabex, Diaformin, Fortamet, Riomet, and Glumetza. Metformin is the only anti-diabetic drug that has been proven to reduce the cardiovascular complications of diabetes, as evidenced in a large study of overweight patients with diabetes. Metformin has been in use around the world for more than 30 years. It remains the most prescribed drug for Type-2 diabetes, a testimony to its efficacy and its prominent place in diabetes therapy. Rose C. Perri, the Generex Chief Operating Officer commented, "we are very pleased to receive the first patent for our metformin gum product, a product that compliments our flagship product, Generex Oral-lyn[TM], and related diabetes pipeline". On a personal note, when I first learned about this development from the masterminds at Generex I was definitely excited. But now that the train has left the station, I'm happy to share this news with the gum-chewing, metformin-taking, diabetes population. It's all about the delivery and this one is definitely special. Read | Permalink | Email this | Linking Blogs | Comments
First Metformin Gum Patent related news:
- 1st Metformin Gum Patent Granted to Generex Biotech — Operations-Related News from StratCenter.com
- Generex Biotechnology: First Metformin Gum Patent Granted to Generex Biotechnology — Market Wire - Pharmaceuticals and Biotech
- SpectraScience files new patent application — News-Medical News Feed
- ProactiveNet Granted U.S. Patent for Correlation and Root Cause of Performance Events and Abnormalities — ArriveNet : Technology
- FFII announces the European Patent Conference — LWN.net
- Non-stick chewing gum jobs boost — BBC News | UK News | Wales | World Edition
- TeleCommunication Systems, Inc.: TCS Marks Milestone 50th Patent — Market Wire - Telecom
- United Therapeutics and Herbalife International Settle All Patent Litigation — PR Newswire: All Releases
- Samba Team Denounces Novell/Microsoft Patent Pact — eWEEK Developer
- Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation — PR Newswire: All Releases